Australian medical and cancer research funding

The Australian government has initiated significant funding programs to bolster medical and cancer research. Recent announcements include $40 million in grants administered by the National Health and Medical Research Council (NHMRC) and the Medical Research Future Fund (MRFF) to support nurses and midwives in clinical research. This includes up to $1.5 million per project focused on health service translation and workforce innovation.

Further investment includes $3.5 million (AUD$5 million) dedicated to bringing international CAR-T cell therapy clinical trials to Australia for children and young people, marking the first step in a decade-long $300 million (AUD) Australian Cancer Research Program.

Broader data indicates that between 2021 and 2025, the NHMRC and MRFF awarded a combined $4.52 billion (AUD 6.46 billion) through over 4,000 grants. Additionally, the Cancer Institute NSW has committed $7.7 million (AUD 11 million) to improve cancer prevention, detection, and treatment in regional and rural communities, with a focus on surgical clinical trials and researcher training.

To address disparities in survival rates, new national optimal care pathways for rural cancer patients have been introduced. Research from Deakin University suggests rural Australians are 13 per cent less likely to survive cancer due to specialist shortages, late diagnoses, and distance to facilities. The National Rural Health Alliance has identified an annual shortfall of $9.23 billion in rural health spending. The new guidelines, developed with the Cancer Council, advocate for care as close to home as possible, increased telehealth usage, and improved travel and financial assistance.